The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer

Sarah Sharman Moser, Frank Tanser, Nava Siegelmann-Danieli, Lior Apter, Gabriel Chodick, Josie Solomon

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences

Chemistry